Evidence map›Paper›PMID 31620082›Full record

ReviewFrontiers in endocrinology2019

Influences of Sex and Estrogen in Arterial and Valvular Calcification.

Bin Zhang, Virginia M Miller, Jordan D Miller

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Sex-Related Effects on Cardiac Development and Disease.Journal of cardiovascular development and disease · 2022
    Review
  17. Oestrogenic Regulation of Mitochondrial Dynamics.International journal of molecular sciences · 2022
    Review
  18. Article
  19. Article
  20. Estrogen and Cardiovascular Health.Frontiers in cardiovascular medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bin ZhangDepartment of Surgery, Mayo Clinic, Rochester, MN, United States.
Virginia M MillerDepartment of Surgery, Mayo Clinic, Rochester, MN, United States.
Jordan D MillerDepartment of Surgery, Mayo Clinic, Rochester, MN, United States.
Mayo Clinic in Arizona · US

Funding

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's DiseaseU54AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MIELKE, MICHELLE M · 2018 to 2022
$7.7M
Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular diseaseR01HL141819 · NHLBI · MAYO CLINIC ROCHESTER · PI MILLER, JORDAN D · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL141819NIA NIH HHS U54 AG044170
6 · The paper itself

Abstract

Vascular and cardiac valvular calcification was once considered to be a degenerative and end stage product in aging cardiovascular tissues. Over the past two decades, however, a critical mass of data has shown that cardiovascular calcification can be an active and highly regulated process. While the incidence of calcification in the coronary arteries and cardiac valves is higher in men than in age-matched women, a high index of calcification associates with increased morbidity, and mortality in both sexes. Despite the ubiquitous portending of poor outcomes in both sexes, our understanding of mechanisms of calcification under the dramatically different biological contexts of sex and hormonal milieu remains rudimentary. Understanding how the critical context of these variables inform our understanding of mechanisms of calcification-as well as innovative strategies to target it therapeutically-is essential to advancing the fields of both cardiovascular disease and fundamental mechanisms of aging. This review will explore potential sex and sex-steroid differences in the basic biological pathways associated with vascular and cardiac valvular tissue calcification, and potential strategies of pharmacological therapy to reduce or slow these processes.

Indexed as

age-related cardiovascular parametersagingaortic valve stenosiscardiovascular calcificationepidemiologyestrogenhemodynamicstestosterone

Identifiers

PMID31620082
PMCPMC6763561
OpenAlexW2970680635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.